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In this paper we demonstrate that modulator sequences upstream of the enhancer of the major immediate-
early promoter of human cytomegalovirus exert a differential effect on the level of transcription in a variety of
cells and that this region has the capacity to interact with specific nuclear protein. Depending on the cell type,
these modulator sequences increased or decreased transcriptional activation from the IEl gene promoter-
enhancer. The cell lines identified in this report should be useful to study the molecular mechanism of
cell-specific transcriptional repression and activation exerted by the major immediate-early promoter upstream
region.
Although human cytomegalovirus (HCMV) nonproduc-
tively infects cells ofmany types from humans (8, 16, 17) and
other species (2, 11), the virus replicates in vitro only in
fibroblasts of human origin. Transcription of the first viral
genes expressed, the immediate-early (IE) genes, are mainly
dependent on host cell factors (1, 5-7, 20, 21), suggesting
that this may constitute the primary event at which expres-
sion of the viral genome is regulated. Regulatory sequences
of the HCMV major IE gene, the IEl gene, encompass a
polymerase II promoter between +1 and -65 (6, 19); a
strong and complex enhancer between -66 and -524 (1, 5,
7), which is active in many different cell types; a cluster of
nuclear factor 1-binding sites between -600 and -720 (9,
10); and modulator sequences between -750 and -1145 (14,
15). These modulator sequences negatively regulate expres-
sion in nonpermissive undifferentiated teratocarcinoma
(Tera-2) cells but positively influence expression in permis-
sive differentiated cells (14, 15). In the present study we have
addressed the question of whether the modulator region is
functional in cell types other than the embryonal carcinoma
cell system and whether indeed it may contribute to cell-
specific expression.
Recombinant plasmids containing the modulator (A1145)
or with the modulator sequences truncated (A525), which
were previously used to define the modulator region (15),
were analyzed for transcriptional activity by transient-trans-
fection experiments in a variety of cells. Monolayer cells
(SW480 and 293) were transfected by the calcium phosphate
technique (15), and nonadherent cells (H9, Jurkat, Nama-
lwa, Raji, and U937) were transfected by the DEAE-dextran
chloroquine technique. Approximately 107 cells were co-
transfected with 30 ,ug of the respective plasmid and 5 ,ug of
the transfected control plasmid pRSVL, a plasmid contain-
ing the luciferase gene under the control of the Rous sarcoma
virus long terminal repeat (LTR) (3). Cells were harvested
after 48 h, and protein reporter functions were assayed as
described previously (15). The relative chloramphenicol
acetyltransferase (CAT) activities directed by plasmids
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A1145 and A525 in cells of various lineages were measured
by scintillation counting of conversion rates from chloram-
phenicol to its acetylated forms. All cells were cotransfected
with pRSV-luciferase as a transfection control (3), and the
results with A1145 and A525 were adjusted according to the
relative luciferase activity in the cell extracts. The effect of
the modulator sequences on CAT activity differed depending
on cell type (Fig. 1). A twofold negative effect was observed
in H9, U937, and SW480 cells, but expression in Jurkat, 293,
Raji, and Namalwa cells was barely affected. In B cells the
expression was augmented about three- to fourfold by the
upstream sequences. These results clearly indicate that the
HCMV modulator sequences can influence IE promoter-
enhancer activity in vivo in cell types other than teratocar-
cinoma cells. In particular, the cis-acting sequences nega-
tively modulate expression in some T cells and rectal
epithelial cells, in which HCMV is found during natural
infection.
To identify functional properties of this region in vitro, we
analyzed transcriptional activities of IE1 promoter-enhancer
templates, with or without the upstream sequences, in
nuclear extracts from a variety of cell lines. Nuclear extracts
were prepared from nuclei (2 x 109 to 5 x 109) of Jurkat,
CEM, H9, U937, Raji, Epstein-Barr virus-transformed B
cells, T47-D, HeLa S3, and 293 cells essentially as described
previously (4). Figure 2A shows runoff transcription prod-
ucts from templates A1145 and A524 with nuclear extracts
from the various cell types. Conditions for in vitro transcrip-
tion were as previously described (5), except that a 30-,ul
reaction volume was used which included 300 ,M CTP,
GTP, and ATP and 70 ,ug of nuclear protein. Although the
transcriptional efficiencies in nuclear extracts from each cell
line varied among preparations, the relative number of
transcriptions of A1145 to A524 in each cell line were similar.
Greatly reduced transcriptional activity from A1145 was
observed in nuclear extracts from CEM, U937, and Raji
cells. Slightly lower levels of repression were detected in
HeLa S3 and H9 cells, whereas extracts from Jurkat, 293,
T47-D, and B cells exerted only a marginal effect.
To assess the extent of specificity of the cell-specific
transcriptional modulation for the HCMV IE1 promoter, we
performed control experiments and analyzed transcription
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FIG. 1. Representative CAT assays demonstrating the effect of
the modulator sequence of HCMV IE promoter-enhancer activity.
H9, SW480, Jurkat, and B cells were transfected with plasmids
containing the CAT gene under the control of the HCMV IE
promoter-enhancer with (A1145) and without (A525) the modulator
sequences. We tested cell extracts (100 p.g) for CAT activity by
resolving chloramphenicol from the acetylated forms by thin-layer
chromatography. All cells were cotransfected with pRSV-luciferase
as a transfection control (3), and extracts were assayed for activity.
The autoradiograms are representative samples of experiments with
these different cell lines.
from two human immunodeficiency virus (HIV) LTR tem-
plates. The HIV LTR has been shown in vivo (18) and in
vitro (13) to contain a negative transcriptional-regulatory
element upstream of -278. In nuclear extracts from CEM,
Raji, T47-D, and B cells, the relative transcriptional activi-
ties of HIV templates with deletion endpoints at -453 and
-278 (Fig. 3B) were significantly different from those ob-
tained with the two IEl templates (Fig. 2B). This suggests
that the negative regulatory element in the HIV LTR is
different from that in the IEl gene. Similar to the IEl
template A1145, the HIV template A453 showed transcrip-
tional inhibition in H9 and U937 extracts. In general, the
observed in vivo modulatory effect correlated well with the
in vitro experiments. However, it should be noted that the in
vitro experiments involve the use of naked DNA templates
with a subfraction of soluble nuclear factors. Also, they do
no exclude the possibility that other sequences have addi-
tional effects. For example, A524 but not A1145 contains
50-base-pair IEl RNA-encoding sequences which may stim-
ulate IEl gene expression in tissue culture cells. Therefore,
such assays may only be a partial reflection of the functional
aspects of a specific region.
Since the activities of the modulator region may be medi-
ated by the binding of transcription factors, we have further
investigated the ability of this region to interact with nuclear
proteins. Initially, HeLa S3 cells nuclear extract was chosen
because of its ability to repress in vitro transcription from
templates containing the modulator region. In an electropho-
retic mobility shift analysis, the PstI-AluI fragment from
-1145 to -773 and nuclear proteins formed one major and
several minor complexes ( Fig. 4A, lane 2), suggesting the
binding of several factors. Competition experiments estab-
lished the sequence specificity of these complexes. The
predominant complex c was inhibited by an excess of the
unlabeled PstI-AluI fragment (Fig. 4A, lane 5) but not by a
fragment from the CAT gene (lane 4) or by restriction
fragments from pUC19 (lane 3). Complex a was inhibited by
the unlabeled probe and by pUC19 fragments but not by the
CAT gene fragment (Fig. 4A). To determine whether the
nucleoprotein complexes were specific to the modulator
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FIG. 2. In vitro transcriptional activity of A1145 and A524. (A)
Runoff transcripts originating at the in vitro start site of the
respective templates are indicated by arrows. The cell lines used to
prepare the nuclear extracts are shown above the correspondingly
numbered lanes. HCMV IEl gene templates were prepared by
cutting the plasmids A1145 (15) and A524 (5) with PuII and HindllI.
HCMV sequences in A1145 are from -1145 to +7, and those in A524
are from -524 to +55. Runoff transcripts originating at the in vivo
start site of the respective templates are indicated by arrows. (B)
Relative transcription of A1145 to A524. Quantitation of transcrip-
tion was achieved by densitometer scanning (model 620 video
densitometer; Bio-Rad Laboratories) of several autoradiograms
corresponding to different exposure times.
region of the IEl gene, competition assays were performed
with two fragments from the IEl gene enhancer and pro-
moter region (5). A 50-fold molar excess of an enhancer
fragment did not compete for binding, whereas the presence
of an enhancer-promoter fragment specifically reduced com-
plex c, but not complex a (Fig. 4A, lanes 6 and 7). It is
possible that the proteins forming complex c recognize
similar sequence structures in the promoter and upstream
regions or that such factor(s) recognize more than one
sequence. On the basis of results from binding assays with
smaller and overlapping restriction fragments, sequences
between -970 and -912 participate in the formation of
complex c (data not shown).
To determine whether nucleoprotein complexes were spe-
cific to HeLa cell nuclear proteins, we analyzed binding to
the modulatory region by using the library of transcription-
ally active nuclear extracts. Nuclear proteins from T cells
(Jurkat, CEM, and H9), monocytes (U937), Burkitt lym-
phoma cells (Raji), Epstein-Barr virus-immortalized B cells,
mammary epithelial cells (T47-D), and embryonic kidney
cells (293) induced the formation of complexes (Fig. 4B) with
similar mobilities to those found in the HeLa cell nuclear
extract. An additional complex with a mobility greater than
that of complex a, but less than that of complex b, was
observed predominantly in the nuclear extract from T47-D
cells and to a lesser extent in extracts from Jurkat and U937
cells (Fig. 4B, lanes 8, 3, and 5, respectively). Complexes a,
b, and c were generated by nuclear factors with similar
H-9 SW480 Jurkat B-cell
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FIG. 3. In vitro transcriptional analysis of the HIV LTR deletion
mutants -453 and -278. (A) Runoff transcripts originating at the in
vivo start site of the respective templates are indicated by arrows.
(B) Relative transcription of -453 and -278. For a description, see
the legend to Fig. 2. HIV templates were prepared by cutting
plasmids containing the HIV LTR 5' deletion mutants 453/80 and
-278/80 ligated to the CAT (18) gene with EcoRI. The resulting
runoff transcripts were about 410 base pairs (13, 18).
efficiencies in each tested extract, suggesting that this mod-
ulator region is a target for related DNA-binding proteins
which are present in all cell types.
Proteins from each of the transcriptionally active nuclear
extracts formed generally similar patterns of protein-DNA
complexes with the modulator region in the mobility shift
assay; we did not observe a simple correlation between the
transcriptional activities and protein binding. This could
reflect the inability of the mobility shift assay to resolve
complexes containing similar and/or posttranslationally
modified proteins. Alternatively, the activity of this region
could be dependent on transcription factors acting through
protein-protein interactions and may not necessarily be
detected in this assay. We also cannot exclude the possibility
that enhancer and promoter sequences absent in the binding
assay are required for the stability of a complex associated
with the modulator region. It has been suggested that nuclear
factor 1-binding sites between -775 and -665 might be
involved in the modulator activities (10, 12, 14, 15). How-
ever, the capacity of nuclear proteins to interact with these
binding sites did not vary significantly among extracts from
the different cell lines (data not shown). Perhaps the simplest
explanation would account for the fact that the IE regulatory
sequences interface with a wide variety of transcription
factors (5-7), and, as a consequence, it is the combinatorial
interactions between those positive and negative elements
within any given cell that ultimately determine the extent of
transcription.
Finally, in this report we have shown that the modulator
region of the HCMV IEl gene modulates the level of
transcription in a cell-specific manner. Indeed, the differen-
tial effect exerted by the modulator region in a variety of cell
types may be an important determinant of viral latency
and/or reactivation. By studying a battery of differentially
FIG. 4. Binding of nuclear proteins to the PstI-AluI (-1145 to
-773) fragment of the HCMV IEl gene. One nanogram of end-
labeled fragment was incubated with 2 ,ug of poly(dI-dC) and 1 ,ug of
nuclear extract. Binding conditions and electrophoresis were as
described previously (6). (A) Mobility shift assay with HeLa cell
nuclear extract and a 50-fold molar excess of different competitor
DNAs. Lane 1, probe alone; lanes 2 to 7, probe with nuclear extract
and the following competitor DNAs: poly(dI-dC) (lane 2), pUC19
cut with HaeIII (lane 3), a 250-base-pair EcoRl-HindIlI fragment
from the CAT gene (lane 4), unlabeled PstI-AluI fragment (lane 5),
enhancer fragment spanning nucleotides -524 to -311 (lane 6),
enhancer-promoter fragment spanning nucleotides -185 to -14
(lane 7). (B) Protein-DNA complexes formed between the PstI-AluI
fragment and nuclear extracts from different cell lines. Lane 1,
probe; lanes 2 to 10, binding with nuclear extracts from CEM cells
(lane 2), Jurkat cells (lane 3), H9 cells (lane 4), U937 cells (lane 5),
Raji cells (lane 6), B cells (lane 7), T47-D cells (lane 8), HeLa S3
cells (lane 9), and 293 cells (lane 10). 0 and P indicate the origin of
the gel and unbound probe, respectively.
active nuclear extracts now at our disposal, it should be
possible to investigate the molecular basis of the influence of
the modulator region on transcription and thus gain a better
understanding of the functioning of the viral nucleic acids in
a cell.
The HIV LTR deletion plasmids described in reference 18 were
generated by S. Josephs and F. Wong-Staal and kindly provided by
R. Robbins.
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